Inventor · disambiguated record
Dorothea Rudolph
Also filed as: RUDOLPH DOROTHEA · RUDOLPH Dorothea Ingrid
8 granted patents·16 pending applications·0 citations·filing 2002–2022
74Inventor score
Files withBOEHRINGER INGELHEIM INT13RUDOLPH DOROTHEA3STEUERNAGEL ARND3TAUBE TILLMANN3DEVELOGEN AG FUR ENTWICKLUNGSB1
Top patents by PatentIndex Score
24 records- 0161US2019240242A1Combination treatment of acute myeloid leukemia and myelodysplastic syndrome iiBOEHRINGER INGELHEIM INT·Filed 2019·Application pending·0 cites
- 0259US11814380B2Benzylamino substituted pyridopyrimidinones and derivatives as SOS1 inhibitorsBOEHRINGER INGELHEIM INT·Filed 2020·Granted Nov 14, 2023·0 cites·14 claims
- 0359US2015031643A1Combination treatment of acute myeloid leukemia and myelodysplastic syndrome iiRUDOLPH DOROTHEA·Filed 2014·Application pending·0 cites
- 0459US2023025452A1Anticancer combination therapyBOEHRINGER INGELHEIM INT·Filed 2022·Application pending·0 cites
- 0558US8076098B2Mnk kinase homologous proteins involved in the regulation of energy homeostasis and organelle metabolismSTEUERNAGEL ARND·Filed 2008·Granted Dec 13, 2011·0 cites·11 claims
- 0657US9956225B2Treatment of myelodysplastic syndromeBOEHRINGER INGELHEIM INT·Filed 2017·Granted May 1, 2018·0 cites·10 claims
- 0754US2017157159A1Combination treatment of acute myeloid leukemia and myelodysplastic syndrome iBOEHRINGER INGELHEIM INT·Filed 2017·Application pending·0 cites
- 0853US2019290652A1Method for treatment of solid malignancies including advanced or metastatic solid malignanciesBOEHRINGER INGELHEIM INT·Filed 2019·Application pending·0 cites
- 0952US2019240241A1Combination treatment of acute myeloid leukemia and myelodysplastic syndrome iBOEHRINGER INGELHEIM INT·Filed 2019·Application pending·0 cites
- 1050US9358233B2Method for treating acute myeloid leukemiaTAUBE TILLMANN·Filed 2011·Granted Jun 7, 2016·0 cites·9 claims
- 1150US8957020B2Mnk kinase homologous proteins involved in the regulation of energy homeostasis and organelle metabolismSTEUERNAGEL ARND·Filed 2011·Granted Feb 17, 2015·0 cites·3 claims
- 1250US8828934B2Mnk kinase homologous proteins involved in the regulation of energy homeostasis and organelle metabolismSTEUERNAGEL ARND·Filed 2011·Granted Sep 9, 2014·0 cites·3 claims
- 1350US2021038602A1Combination treatment of acute myeloid leukemiaBOEHRINGER INGELHEIM INT·Filed 2019·Application pending·0 cites
- 1449US2015031642A1Combination treatment of acute myeloid leukemia and myelodysplastic syndrome iRUDOLPH DOROTHEA·Filed 2014·Application pending·0 cites
- 1546US2017157158A1Combination treatment of acute myeloid leukemia and myelodysplastic syndrome iiBOEHRINGER INGELHEIM INT·Filed 2017·Application pending·0 cites
- 1645US2016303131A1Method for treatment of solid malignancies including advanced or metastatic solid malignanciesBOEHRINGER INGELHEIM INT·Filed 2016·Application pending·0 cites
- 1745US2005080026A1Mnk kinase homologous proteins involved in the regulation of energy homeostasis and organelle metabolismFiled 2002·Application pending·0 cites
- 1844US2015031699A1Treatment of myelodysplastic syndromeRUDOLPH DOROTHEA·Filed 2014·Application pending·0 cites
- 1943US2020101079A1Anticancer combination therapyBOEHRINGER INGELHEIM INT·Filed 2018·Application pending·0 cites
- 2042US2013131069A1Method for treatment of solid malignancies including advanced or metastatic solid malignanciesTAUBE TILLMANN·Filed 2012·Application pending·0 cites
- 2139US2016243124A1Method for treating acute myeloid leukemiaBOEHRINGER INGELHEIM INT·Filed 2016·Application pending·0 cites
- 2233US2008226638A1Modifier of Organelle MetabolismDEVELOGEN AG FUR ENTWICKLUNGSB·Filed 2007·Application pending·0 cites
- 2332US9867831B2Combination treatment of acute myeloid leukemia and myelodysplastic syndromeBOEHRINGER INGELHEIM INT·Filed 2015·Granted Jan 16, 2018·0 cites·15 claims
- 2432US9370535B2Method for treatment of advanced solid tumorsTAUBE TILLMANN·Filed 2012·Granted Jun 21, 2016·0 cites·8 claims
Join the waitlist — get patent alerts
Get an alert when Dorothea Rudolph files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →